In recent weeks, lawmakers in several states have moved forward with legislative proposals to permit specific strains and/or extracts of cannabis possessing high quantities of the cannabinoid cannabidiol (CBD), but otherwise maintaining criminal prohibitions on the whole plant.
But is this new direction in the best interest of patients? As I wrote in a recent column for Alternet.org (republished with permission by Cannabis Now under the title “Patients Ought To Be Skeptical Of Proposed CBD-Only Legislation — Here’s Why”), I believe the answer is ‘no.’
Ultimately, patients should not be unnecessarily forced to decide between either accessing the whole plant or its isolated components. They should have safe, legal access to both, and politicians, even well-intentioned ones, should not restrict patients’ right to choose the most suitable option.
Below are excerpts from my commentary. You can read the entire text here.
Patients Ought To Be Skeptical Of Proposed CBD-Only Legislation — Here’s Why
via Cannabis Now
[excerpt] If the plant ain’t broke, why fix it?
For longtime marijuana law reformers, the ongoing political conversation surrounding CBD is instructive. It makes it clear that many politicians’ public opposition to the idea of patients using marijuana therapeutically isn’t because of supposed unanswered questions surrounding the plant’s safety or efficacy. Rather, it is because lawmakers oppose the idea of some people getting high from a naturally growing herb. (The fact that patients can get equally high or even higher from FDA-approved synthetic THC has, for whatever reason, never been an expressed concern of either lawmakers or prohibitionists.) After all, the very same politicians who argue that marijuana isn’t medicine because it hasn’t been approved by the FDA or who allege that the substance hasn’t yet been subjected to sufficient scientific scrutiny utter no such public objections to the idea of legalizing patient access to CBD – a schedule I compound that hasn’t been reviewed, much less approved by the FDA, and that has been clinically studied far less than cannabis.
Perhaps most ironically is that were it not for the advent of legalized whole plant marijuana, a policy change publicly opposed by many present day CBD-only political advocates, lawmakers (and anti-pot groups like SAM) today wouldn’t be aware of CBD, much less advocating for it. The reality is that it was the stakeholders in medical marijuana states, and those who provide for them, who have done the most to explore and promote cannabidiol as a legitimate therapeutic agent. And they were able to do so because they, unlike most federally licensed medical researchers, had access to the whole plant.
We’ve been down this road before. Not long ago, lawmakers and anti-marijuana zealots were dismissing patients’ desire to access the marijuana plant because they alleged that the THC-pill Marinol could adequately meet patients’ needs. Patients and their advocates were skeptical of lawmakers’ claims then, and properly so. Now many of these same politicians are once again dismissing patients’ calls for whole plant medicine by claiming that products and strains containing CBD alone only will suffice. Patients and their advocates ought to be equally skeptical once again.
On Sunday February 16th, I bought legal weed for the first time from a recreational cannabis store in Denver, Co. I spent a few minutes speaking with some of the employees, as I was eager to hear how things were going under this newly sanctioned marijuana market. Unsurprisingly, business was great. Some items were selling quicker than others, but everyone was in agreement that the rollout of Colorado’s legal cannabis retail system had been a great success, except for one crucial component that was as unsettling as it was expected – we were standing in one of a few dozen high profile stores, well-known for having excessive amounts of cash on hand (in the first week of sales, businesses generated $5 million in cash-only transactions) and no where to put it, because the banks won’t take it.
Clearly, denying these pot stores the ability to safely deposit their earnings poses an imminent threat to public safety. These shops are easy targets for robbery and assault (as well as other forms of criminal activity), which puts customers and employees at serious risk. Some of these shop owners are considering banning backpacks or other large bags – others are arming their workers. Neither of these options are a viable solution.
This problem isn’t new however, nor is it going unnoticed. On February 14th, the Department of Treasury released a nonbinding memorandum, in conjunction with the Justice Department stating that banks may consider working with pot retailers without fear of prosecution – so long as they remain in compliance with state laws, and followed other instructions outlined in the memo. Though a truly historic and progressive action by the federal government’s leading financial regulatory body, these guidelines are largely symbolic, providing no actual legal protection to banks working with cannabis shops. As such, most financial companies remain skeptical about getting involved with a market existing under so many contradictory laws.
According to federal law, these banks could technically be found guilty of money laundering (among other offenses) for handling the proceeds of what the US government still considers an illegal drug. The Colorado Bankers Association rightly notes that the guidance issued by the Department of Justice and the U.S. Treasury “only reinforces and reiterates that banks can be prosecuted for providing accounts to marijuana related businesses.” The Association further criticizes these new guidelines, stating that “Bankers had expected the guidance to relieve them of the threat of prosecution should they open accounts for marijuana businesses, but the guidance does not do that. Instead, it reiterates reasons for prosecution and is simply a modified reporting system for banks to use. It imposes a heavy burden on them to know and control their customers’ activities, and those of their customers.”
Is it any surprise then that these guidelines – which include a multi-tiered labeling structure and a requirement for banks to maintain ‘suspicious activity reports’ – have left many financial institutions with cold feet? Two of Colorado’s largest banks, Wells Fargo and FirstBank have already announced they won’t work with weed-related enterprises. In fact, most financial trade associations have widely rejected these latest overtures because there are no tangible, legal policies in place.
Despite the skepticism held by many federal administration officials and other politicians, the government can and should be doing much more to enable the success of this new, legal market. Unfortunately, many are sitting on their hands, and holding their breath – hoping to quietly ride out this growing wave of support for legalization, which shows no sign of subsiding. Over 50% of the US population supports a regulated marijuana retail system for adults.
Its time for these officials to concede to the will of the electorate, and address the legitimate needs of this new industry. Lawmakers now have an opportunity to show true leadership in this changing political landscape by supporting legislation that would give states and businesses the resources necessary to enable a responsible and successful implementation of this new “great experiment.” Specifically, they should get behind the “Marijuana Businesses Access to Banking Act,” introduced by Colorado representative Ed Perlmutter. This bill (HR 2652), already endorsed by the Colorado Bankers Association, would alter various banking laws to protect banks providing services to marijuana-related businesses from the threat of federal prosecution and other penalties.
Financial institutions don’t operate off good-faith statements (including non-binding memorandums) – even those from the Department of Treasury, or any other enforcement agency. They operate under explicit legal authorization. Only when the laws change will the banks truly be free to provide the services these businesses so desperately need, and their communities rightly deserve.
Contact your representative today and tell them to support HR 2652
CNN Chief Medical Correspondent Dr. Sanjay Gupta is “doubling down” in his advocacy for patients to have legal access to cannabis as a therapeutic agent.
In a commentary featured on the CNN website today, Gupta writes: “I am more convinced than ever that it is irresponsible to not provide the best care we can, care that often may involve marijuana. I am not backing down on medical marijuana; I am doubling down.”
Last August, Gupta authored a commentary apologizing for his past opposition to medical cannabis, stating, “We have been terribly and systematically misled for nearly 70 years in the United States (in regards to cannabis), and I apologize for my own role in that.”
In today’s editorial, Gupta acknowledges, “Marijuana is classified as a Schedule I substance, defined as (one of) the most dangerous drugs with no currently accepted medical use. Neither of those statements has ever been factual.”
He criticizes President Obama for acknowledging that cannabis poses less harm than alcohol while failing “to remove marijuana from the list of the most tightly controlled substances in the country.” Dr. Gupta also questions how the US government can possess a patent on the therapeutic application of cannabinoids yet still deny that the compounds possess medical utility.
Ultimately, cannabis prohibition is a “Draconian system where politics override science,” Gupta concludes.
Gupta’s forthcoming documentary on the plant, entitled “Weed 2: Cannabis Madness: Dr. Sanjay Gupta Reports,” at 10 p.m. ET on Tuesday, March 11.
Members of the Washington DC City Council gave final approval today to legislation reducing the District’s marijuana possession penalties to a fine-only violation.
District lawmakers voted 10 to 1 in favor of “The Simple Possession of Small Quantities of Marijuana Decriminalization Amendment Act of 2013,” which amends District law involving the possession or transfer of up to one ounce of marijuana from a criminal misdemeanor (punishable by up to 6 months incarceration and a maximum fine of $1,000) to a civil violation (punishable by a $25 fine, no arrest, no jail time, and no criminal record). Democrat Mayor Vincent C. Gray said that he intends to sign the measure into law.
Offenses involving the public consumption of cannabis remain classified as a criminal misdemeanor under DC law, punishable by up to six-months in jail and a $500 fine. The possession of cannabis-related paraphernalia will be re-classified as a violation, not a criminal offense.
Once signed into law, the measure faces a 60-day review period by members of Congress.
The District measure is similar to existing ‘decriminalization’ laws in California, Connecticut, Maine, Massachusetts, Nebraska, New York, Oregon, Rhode Island, and Vermont where private, non-medical possession of marijuana is treated as a civil, non-criminal offense.
Five additional states – Minnesota, Mississippi, Nevada, North Carolina, and Ohio – treat marijuana possession offenses as a fine-only misdemeanor offense.
Three states – Alaska, Colorado, and Washington – impose no criminal or civil penalty for the private possession of small amounts of marijuana.
A 2012 analysis published by the American Civil Liberties Union of Maryland reported that the District possesses the highest percentage of marijuana possession arrests per capita in the nation.
(Dr. Mitch Earleywine was elected as the Chairman of the NORML Board of Directors in February 2014)
A recent headline reads: “Can Marijuana Kill You? German Scientists Say Yes.” The article focuses on a study of two (count ‘em, two!) young men who died while they had detectable levels of THC in their blood. I take a lot of pleasure in this kind of melodrama. If prohibitionists are stooping this low, we must really be frightening them. (It’s not completely pharmacologically ridiculous. Marijuana does increase heart rate. In fact, it can jack up heart rate almost as much as an espresso or energy drink. Maybe if you already had a weak heart and a coffee and a bong hit, well, something might happen.)
But I want to point out that we should actually expect literally thousands of reports like this. We should hear about lots of people who have heart attacks on the same day that they commune with the plant. It’s not because cannabis causes heart attacks. It’s simple chance.
I hate for my first blog as Chair of The Executive Board to be this nerdy, but I’ve been teaching statistics for more than 20 years. If that doesn’t make me a nerd, I’m not sure what would. But given how many people use cannabis daily and how many heart attacks occur in the United States, it’s actually a miracle that we haven’t heard about this kind of thing before. We also should expect to hear it a lot more often.
According to the National Survey on Drug Use and Health, roughly 7,600,000 Americans (over age 12) used marijuana daily or near daily in 2012. In addition, the Center for Disease Control suggests that about 715,000 of us have heart attacks in a year. (Let’s assume those under age 12 are probably not grabbing their chests with a myocardial infarction too often.) In addition, let’s guess that the United States has about 280 million people over age 12. It’s hard to know the exact number, but that’s probably in the ballpark.
With this in mind, we can predict how many people should have a heart attack the same day that they used cannabis simply by chance. That is, even if these two things had nothing to do with each other, we should expect some folks to have a heart attack the same day that they used cannabis just by accident.
Okay. It’s going to get nerdy here, but this is comparable to asking simpler questions. If I had a dime and a nickel, I might want to know what the chances are that I’d flip heads on both. I flip heads 1 out of 2 times on average for the dime, for a probability of .5. Then I flip heads on the nickel 1 out of 2 times on average, also for a probability of .5. So the chances of flipping heads on both is .5 * .5 for .25. So we’d expect to get heads on both coins about 1Ž4 of the time. If I flipped both coins 100 times, I’d get around 25 pairs of heads. Note that there’s nothing causal here. The nickel doesn’t know what the dime did. It doesn’t want to be like the dime. It’s not that the dime caused the nickel to flip heads.
So it’s the same deal for the cannabis-related heart attacks. If 7.6 million people use cannabis daily out of 280 million relevant Americans, that’s a probability of .0271. And if 715 thousand of 280 million have heart attacks, that’s a probability of .0026. Multiply these the same way we did with the probabilities for flipping heads (.0271 * .0026 = .00007). Now .00007 is a dinky number. If there were only 100 people in the country, we wouldn’t expect any of them (well, .007) to have a heart attack and smoke cannabis on the same day. But we’re talking about 280 million people here. So we’d expect .00007 * 280,000,000, = 19,600. That’s over 19,000 heart attacks.
So the question isn’t, “How did these two guys die of a heart attack with THC in their blood?” It should be, “Where are the other 19,598 guys who should have had heart attacks with THC in their blood?” In fact, the absence of this many cannabis-related myocardial infarctions inspired my wife to ask, “Does cannabis protect the heart?”
If we repeal prohibition, we’ll get to find out.
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013 Jan 1;127(1):e6-e245.
Substance Abuse and Mental Health Services Administration, Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013.
Members of the National Black Caucus of State Legislators recently resolved at their Annual Legislative Conference in favor of decriminalizing marijuana.
“Whereas state and local governments could potentially stand to save billions of dollars that they currently spend regulating marijuana use by decriminalizing the recreational use of marijuana, therefore be it resolved that the National Black Caucus of State Legislators recognizes the decision of the Administration to not challenge the choice made by citizens of these states, and urges the continued respect of state law, and encourages other states to consider decriminalization,” the Caucus resolved.
It added, “[The] NBCSL supports the states’ authority to make a determination as to what age, at or above 18, qualifies as a “legal adult” who may purchase, possess, or consume marijuana [and] … urges the federal government to reduce the penalties associated with the use and simple possession of marijuana.”
The 2014 resolution is LJE-14-40: Supporting States’ Rights to Decriminalize Marijuana Use.
A 2013 report by the American Civil Liberties Union reported that blacks nationwide were approximately four times as likely as whites to be arrested for marijuana possession in 2010, even though both ethnic groups consumed the substance at similar rates.
The National Black Caucus of State Legislators represents more than 650 African-American legislators from 45 states, the District of Columbia, and the Virgin Islands.
NORML filed an “amicus curiae” brief with the Massachusetts Supreme Court on Tuesday, February 18, urging the court to place more limits on police questioning and searches for possession of small amounts marijuana. Attorneys Steven S. Epstein, of Georgetown, and Marvin Cable, of Northampton, authored the brief.
In Western Massachusetts, a judge ruled that based on the odor of raw marijuana an officer could question the defendant about the presence of marijuana and seize a bag of marijuana at the direction of defendant in response to those questions. She reasoned, “a strong odor of marijuana to the officers training and experience triggered a suspicion that there was more than one ounce present.” That suspicion justified asking the Defendant about it and police entering his car to retrieve the marijuana he told them was there.
She further ruled that once police retrieved that bag they lacked the authority to search for more marijuana. She reasoned that a belief the bag was “probably” a criminal amount alone and combined with an officer’s characterization of the odor as “strong” amounted to nothing more than a “hunch.” She ordered the “other bags and the statements subsequently made by the defendant” could not be used at trial. The state appealed.
In its friend of the court brief, NORML reminds the Court of the precarious constitutionality of marijuana prohibition. It then proceeds to ask the Court to rule that: a police officer may not question a person about possible marijuana in his possession or control based only on the officer’s perception of odor, a civil violation in Massachusetts; and, that absent objectively reasonable evidence derived from weighing a bag suspected of containing over an ounce police may not detain, arrest or search a person or their possessions.
NORML argues the citizens of Massachusetts by voting to decriminalize an ounce or less of marijuana do not want police bothering people with anything more than a ticket when there are no articulated facts that a suspected possession of marijuana is criminal in nature. One of the intents of the decriminalization law was to free police to pursue more pressing issues than marijuana possession.
Oral argument in the case of Commonwealth v. Overmyer is scheduled for March 3, with a decision possible before the summer of 2014.
Polling data released today by Quinnipiac University revealed that a majority of Ohio voters support legalizing marijuana for recreational use and nearly 9 out of 10 support legalizing marijuana for medicinal use.
When asked if they supported or opposed allowing adults in Ohio to legally possess small amounts of marijuana for personal use, 51% said they would support this policy and only 44% were opposed. Support was strongest amongst voters age 18-29 (72%), Independent voters (61%), and Democrats (54%) and weakest among Republicans (33%) and voters over the age of 65 (31%).
Essentially all voters stated they supported legalizing marijuana for medicinal use. 87% said they supported allowing marijuana for medical use and just 11% were opposed. No demographic had less than 78% support.
Rob Ryan, Ohio NORML President, is not surprised by the favorable Quinnipiac poll response. In his experience speaking to various non marijuana groups, even the most conservative citizens in south west Ohio, where Mr. Ryan lives, readily agree that marijuana is not a deadly, addictive drug with no medical use as it is defined by to be in the same class as heroin by state and federal law.
You can view the full results of the poll here.
On Friday, more than 40 state lawmakers in Maine co-signed a memo authored by State Representative Diane Russell that was delivered to the Appropriations & Financial Affairs Committee. The memo encouraged the committee to keep all options on the table in their upcoming financial deliberations, including potential tax revenue derived from an adult, non-medical market for marijuana.
“All options should be on the table,” Rep. Russell stated in the memo, “In this spirit, we propose committee members give serious consideration to the revenue options associated with legalizing, taxing and regulating cannabis for responsible adult use.”
The memo was signed by prominent elected officials in the state including Majority Leader Troy Jackson (D-Allagash), House Majority Leader Seth Berry (D-Bowdoinham), Minority Whip Alex Willette (R-Mapleton), House Chair of Criminal Justice and Public Safety and former County Sheriff Rep. Mark Dion (D-Portland), and House Health and Human Services Committee Chairman Richard Farnsworth (D-Portland).
In 2013, the Maine House of Representatives fell just four votes short of approving a measure introduced by Rep. Russell which would have placed the issue of marijuana legalization before voters during the fall elections.
Last week, initial tax revenue estimates for the sales tax on recreational marijuana in Colorado were estimated to be just shy of 100 million dollars, far higher than the initial 70 million dollar estimate given to voters in 2012.
“Shenna Bellows has been at the forefront of the fight for marijuana legalization even before beginning this campaign,” stated NORML PAC Manager Erik Altieri, “During her tenure leading the Maine ACLU, Shenna has demonstrated she has the skill and determination to fight for sensible reforms and has proven to be a vocal and articulate leader in calling for the end of marijuana prohibition. We believe she will be invaluable in the United States Senate to help move the country away from our failed war on marijuana and towards a new, smarter approach.”
“We need to end the war on drugs and reform our criminal justice system, and we cannot afford to wait. The United States incarcerates more people in total and more people per capita than any other country in the world, and the racial disparities are alarming,” Shenna Bellows wrote in a recent op-ed, “Even in my home state of Maine, which is the whitest state in the union, blacks are 2.1 times more likely than whites to be arrested for marijuana possession. Government spends billions of dollars each year enforcing counterproductive drug laws, which are truly the New Jim Crow. The economic and human rights costs are enormous.”
While we have long had support for marijuana law reform in the House of Representative, support in the Senate has long been harder to come by. In a recent interview with ThinkProgress, Ms. Bellows has made clear she looks to kickstart the movement for rational marijuana policy in the upper chamber of Congress.
“Right now on the Senate side, there doesn’t seem to be a leader who has the courage to move that forward,” Bellows said. “I would be that leader.”
You can donate to the NORML PAC to help elect pro-reform candidates nationwide here.
Most New York state voters support regulating the adult use of cannabis, while a super-majority endorse legalizing the plant for therapeutic purposes, according to a recently released Quinnipiac University poll.
Fifty-seven percent of respondents support “allowing adults in New York State to legally possess small amounts of marijuana for personal use.” Only 39 percent of respondents opposed the idea.
Respondents most likely to favor legalization include those age 18 to 29 (83 percent), Democrats (65 percent), those age 30 to 49 (61 percent), and men (63 percent). Support is significant lower among women (51 percent), Republicans (39 percent), and those over the age of 65 (38 percent).
On the issue of legalizing cannabis for therapeutic purposes, voter support rose to 88 percent — with the issue receiving super-majority support from respondents of every age and political affiliation.
In separate questions, only 13 percent of respondents say that they believe that cannabis is “more dangerous” than alcohol, and fewer than half believe that it is a ‘gateway’ to other illicit substance use.
The survey possesses a margin of error of +/- 2.5 percentage points.
Legislation to legalize the possession, cultivation, and retail sale of the plant — the “Marihuana Regulation and Taxation Act” — is pending in both the New York state Senate and the Assembly. Separate legislation to allow qualified patients to possess and purchase cannabis for therapeutic purposes also remains pending.
In January, Democrat Gov. Andrew Cuomo — who had previously expressed opposition to allowing for the medical use of cannabis — announced plans to use his executive powers to revive a dormant research program that would allow for the use of government-grown marijuana in select hospitals. However, efforts to reestablish similar programs in other states have not been effective.
Today, the Department of Justice and the Financial Crimes Enforcement Network division of the Treasury Department released long anticipated guidance to banks and other financial institutions on how they can interact with marijuana businesses that are licensed under state law.
Under current regulations, financial institutions are required to file suspicious activity reports when they suspect the transaction has a drug connection. The new guidance creates a three tiered system for these reports: marijuana limited, marijuana priority, and marijuana termination. This will allow these institutions to work with marijuana businesses as long as they were operating in accordance with state laws and regulations. The Department of Justice reserved the right to pursue criminal charges when they suspect businesses are breaking the guidelines they released late last year and would still require banks to report any activity they suspect to be as operating outside of state regulations.
“Now that some states have elected to legalize and regulate the marijuana trade, FinCEN seeks to move from the shadows the historically covert financial operations of marijuana businesses,” noted FinCEN Director Jennifer Shasky Calvery in a press release. “Our guidance provides financial institutions with clarity on what they must do if they are going to provide financial services to marijuana businesses and what reporting will assist law enforcement.”
“This reduces the burden on banks,” FinCEN stated during a briefing on the memo, “Marijuana under federal law requires a SAR. Now, the necessity is limited, reducing the banks’ burden a bit and more importantly clarifies where law enforcement focuses its attention.”
While this is a good start when it comes to allowing marijuana businesses to operate the same as those in any other regulated industry, memos such as these can be ultimately overturned by future administrations. To make this change lasting and binding, Congress must now act to codify it into law. The Marijuana Business Access to Banking Act is currently pending before the House of Representatives and would do just that. You can click here to quickly and easily write your representative and urge him/her to support this important legislation.
Representative Steve Cohen (D-TN) has introduced federal legislation, House Resolution 4046, to remove legal restrictions prohibiting the Office of National Drug Control Policy from researching marijuana legalization. These restrictions also require the office to oppose any and all efforts to liberalize criminal laws associated with the plant.
“Not only is the ONDCP the only federal office required by law to oppose rescheduling marijuana even if it is proven to have medical benefits, but it is also prohibited from studying if that could be even be true,” said Congressman Cohen. “The ONDCP’s job should be to develop and recommend sane drug control policies, not be handcuffed or muzzled from telling the American people the truth. How can we trust what the Drug Czar says if the law already preordains its position? My bill would give the ONDCP the freedom to use science—not ideology—in its recommendations and give the American people a reason to trust what they are told.”
These restrictions were placed on the Office of National Drug Control Policy by the Reauthorization Act of 1998, which mandates the ODCP director “shall ensure that no Federal funds appropriated to the Office of National Drug Control Policy shall be expended for any study or contract relating to the legalization (for a medical use or any other use) of a substance listed in schedule I of section 202 of the Controlled Substances Act (21 U.S.C. 812) and take such actions as necessary to oppose any attempt to legalize the use of a substance (in any form) that–
(A) is listed in schedule I of section 202 of the Controlled Substances Act (21 U.S.C. 812); and
(B) has not been approved for use for medical purposes by the Food and Drug Administration;”
You can quickly and easily contact your representative by clicking here.
Earlier today, 18 members of Congress signed onto a letter that was delivered to President Barack Obama calling for him to remove marijuana from Schedule I of the Controlled Substances Act.
“We request that you take action to help alleviate the harms to society caused by the federal Schedule I classification of marijuana. Lives and resources are wasted on enforcing harsh, unrealistic, and unfair marijuana laws,” the letter reads, “Nearly two-thirds of a million people every year are arrested for marijuana possession. We spend billions every year enforcing marijuana laws, which disproportionately impact minorities. According to the ACLU, black Americans are nearly four times more likely than whites to be arrested for marijuana possession, despite comparable usage rates.”
The letter was signed by Representatives Blumenauer (OR), Cohen (TN), Farr (CA), Grijalva (AZ), Honda (CA), Huffman (CA), Lee (CA), Lofgren (CA), Lowenthal (CA), McGovern (MA), Moran (VA), O’Rourke (TX), Polis (CO), Quigley (IL), Rohrabacher (CA), Schakowsky (IL), Swalwell (CA), and Welch (VT).
“Classifying marijuana as Schedule I at the federal level perpetuates an unjust and irrational system. Schedule I recognizes no medical use, disregarding both medical evidence and the laws of nearly half of the states that have legalized medical marijuana,” the letter continued, “A Schedule I or II classification also means that marijuana businesses in states where adult or medical use are legal cannot deduct business expenses from their taxes or take tax credits due to Section 280E of the federal tax code. We request that you instruct Attorney General Holder to delist or classify marijuana in a more appropriate way, at the very least eliminating it from Schedule I or II.”
You can read the full text of the letter here.
At a press conference this afternoon, State Senator Josh Miller (D-Cranston) and Representative Edith H. Ajello (D-Providence) will announce and discuss their proposed legislation that would make Rhode Island the third state in the country to legalize and regulate the possession, cultivation, and retail sale of cannabis for adults.
This legislation would allow adults 21 and older to possess up to one ounce of marijuana and grow up to two marijuana plants in an enclosed, locked space. It would establish a tightly regulated system of licensed marijuana retail stores, cultivation facilities, and testing facilities.
“Rhode Island now joins over a dozen other state legislatures that are debating measures to legalize marijuana this year,” stated NORML Communications Director Erik Altieri, “A majority of Rhode Island voters, and Americans in general, support replacing our failed prohibition policy with one of regulation. Elected officials are wise to see that the desires of their constituents are being represented and we commend Representative Ajello and Senator Miller for being leaders on this issue.”
RHODE ISLAND RESIDENTS: Please consider calling your members of the state Senate and House of Representatives to urge them to co-sponsor this important legislation. Click here to find out who your elected officials are and their contact information.
Hi my name is (name), and I live in (city/town) in your legislative district. As you might know (Chairwoman Edith Ajello/Senator Josh Miller) is introducing a bill to tax, regulate, and control marijuana like alcohol. (He/She) is currently recruiting co-sponsors for this important bill. Our current policy of marijuana prohibition has been a total failure, and when something is broken, it needs to be fixed. Regulating marijuana is the right solution because it would take control away from illegal dealers, and it would help Rhode Island’s economy. I urge you to join (Chairwoman Ajello/Senator Miller) and co-sponsor this sensible legislation. Thank you.
NORML will keep you updated as this legislation moves forward.
Nearly 30 states, and the District of Columbia are considering marijuana law reform legislation this year, including bills that cover legalization for adults, decriminalization, medical marijuana and hemp. Some states have a variety of reform bills simultaneously pending such as Arizona which is considering legalization and decriminalization, and Pennsylvania which is considering legalization as well as medical marijuana legislation. Here’s a quick breakdown:
14 states are considering legalization: Arizona, Hawaii, Maryland, Massachusetts, Missouri, New Hampshire, New Jersey, New York, Oklahoma, Oregon, Pennsylvania, Rhode Island, Vermont, and Wisconsin.
12 states and the District of Columbia are considering decriminalization: Alabama, Arizona, DC, Hawaii, Illinois, Louisiana, Michigan, Missouri, New Hampshire, New York, North Carolina, South Carolina, and Wyoming.
11 states are considering legislation to establish effective medical marijuana programs: Florida, Kansas, Kentucky, Hawaii, Michigan, New York, Pennsylvania, Tennessee, West Virginia, Minnesota and Wisconsin.
3 states are considering allowing industrial hemp cultivation: Indiana, New York, and Tennessee.
Click here to access NORML’s Action Alerts and quickly and easily contact your elected officials to encourage their support of any pending reform bills. Be sure to keep checking NORML’s Take Action Center to see if your state has joined the list!
Alaska: Election Officials Affirm Legalization Measure Has Enough Signatures To Qualify For The 2014 Ballot
State election officials have affirmed that a proposed initiative to regulate the production and retail sale of cannabis to adults has obtained the necessary number of signatures from registered voters to appear on 2014 ballot.
The initiative’s proponents, The Campaign to Regulate Marijuana in Alaska, gathered more than 45,000 signatures from registered Alaska voters. On Tuesday, the director of the Alaska’s Division of Elections confirmed that of those signatures, 31,593 have been verified, thus qualifying the measure for a public vote. The lieutenant governor’s office is expected to certify the measure for the 2014 ballot in the coming days, once all of the remaining signatures have been counted and verified.
Once certified, the initiative will be placed on the August 19 primary election ballot, as is required by Alaska election law.
If approved by voters, the measure would legalize the adult possession of up to one ounce of cannabis as well as the cultivation of up to six-plants (three flowering) for personal consumption. The measure would also allow for the establishment of licensed, commercial cannabis production and retail sales of marijuana and marijuana-infused products to those over the age of 21. Commercial production and retail sales of cannabis would be subject to taxation, but no taxes would be imposed upon those who choose to engage in non-commercial activities (e.g., growing small quantities of marijuana for personal use and/or engaging in not-for-profit transfers of limited quantities of cannabis.) Public consumption of cannabis would be subject to a civil fine.
The measure neither amends the state’s existing medical marijuana law, which was approved by voters in 1998, nor does it diminish any privacy rights established by the state’s Supreme Court in its 1975 ruling Ravin v State.
Under present state law, the possession of marijuana not in one’s residence is classified as a criminal misdemeanor punishable by up to 90-days in jail and a $2,000 fine.
According to the results of a statewide Public Policy Polling survey, released today, 55 percent of registered voters “think (that) marijuana should be legally allowed for recreational use, that stores should be allowed to sell it, and that its sales should be taxed and regulated similarly to alcohol.” Only 39 percent of respondents oppose the idea. The survey possesses a margin of error of +/- 3.4 percent.
Additional information about the campaign is available here.
At eight o’clock this morning, Iraq War Veteran Sean Azzariti stepped up to the counter at 3D Cannabis Center in Denver and made the first ever legal marijuana purchase in the United States. He didn’t have to show a medical marijuana program card, proving he paid a fee and consulted a doctor, he simply flashed his driver’s license to confirm he was over 21 and bought his cannabis products. This is a first for Sean, who uses cannabis to treat his PTSD, as his ailment was not an authorized qualifying condition for the Colorado medical marijuana program.
The first purchase? 3.5 grams of Bubba Kush and a marijuana infused truffle. Total cost? 58.74 with tax included ($40 plus tax for the Kush and $9.28 plus tax for the truffle. You can view his receipt he tweeted out here.)
So far, the 34 stores that were open for business today are reporting massive lines, but no real problems. The sky has yet to fall, drivers aren’t crashing continuously into buildings, violence has not erupted in the streets. Maybe it is possible, after decades of scare mongering, that regulation just might be the better alternative after all? The program is still in it’s beginning stages, and will naturally need fine tuning along the way, but so far it is already looking like a widely better solution than prohibition ever was. Judging by the lines that extended far outside the door and around the building at all of the retail locations, Coloradans seem to be very eager to give regulation a chance. Let’s work together to ensure this program works and that it sets the shining example for all other states to follow in the coming years nationwide.
Congratulations to Colorado and all those who worked so hard to get us to this point. It is truly a historic day.
The eyes and ears of the national and international media will be focused on Colorado on New Year’s Day as the nation’s first modern state-licensed retail cannabis dispensaries will be open for business.
Late last week, state and local regulators signed off on the first wave of licensed cannabis businesses, with hundreds more applicants awaiting final approval. (See the actual state-approved marijuana business license via today’s CNN video here.)
The Colorado NORML website has posted a clock counting down the hours and minutes until the nation’s first recreational cannabis sales become reality here. They also provide a statewide list of licensed cannabis retailers, as well as a ‘consumers’ guide’ to complying with Colorado state law here.
Like I told USA Today in its coverage today, “The genie’s out of the bottle and it’s simply not going back in.”
#1 Public Support For Legalizing Marijuana Hits Historic Highs
An unprecedented 58 percent of Americans believe that marijuana ought to be “made legal” for adult consumption, according to survey data reported in October by Gallup. The percentage is the highest level of support ever recorded by Gallup, which has been inquiring on the issue since 1969, and marks a ten percent increase in voter approval since 2012. Regional polls conducted this year in several states, including California, Louisiana, and Texas, also reported majority support for legalization.
#2 Nation Of Uruguay Passes Legislation Regulating Cannabis Use
Lawmakers in the South American nation of Uruguay enacted legislation authorizing the licensed production and retail sale of cannabis to all citizens age 18 and older. Residents will be able to legally purchase up to 40 grams of cannabis per month from state-licensed stores at a price of $1 per gram. Uruguay is the first country in modern history to officially legalize and regulate the licensed production and retail sale of cannabis.
#3 Feds Pledge Not To Interfere In State-Licensed Retail Sales Of Cannabis
Deputy Attorney General James Cole issued a three-page memorandum in August affirming that the US Justice Department will allow Colorado and Washington to move forward with statewide efforts to license and regulate the adult marijuana market. Cole later reaffirmed the agency’s position in testimony before the US Senate, stating, “We will not … seek to preempt state ballot initiatives.”
#4 States Finalize Regulations Governing Adult Cannabis Sales
Regulators in Colorado and Washington this fall began accepting applications from businesses seeking to engage in the licensed cultivation, production, and retail sale of cannabis and cannabis-infused products. In Washington, several thousand applicants have applied to pot business licenses. In Colorado, regulators have begun approving licenses and several commercial establishments are expected to be open for business on January 1, 2014.
#5 Record Number Of Statewide Marijuana Reform Measures Enacted Into Law
Lawmakers in a dozen states approved some 20 pieces of marijuana law reform legislation in 2013. Specifically, lawmakers in Colorado and Vermont enacted legislation licensing commercial hemp production; Illinois and New Hampshire legalized the use and distribution of marijuana for medical purposes; Oregon and Nevada approved regulations allowing for the establishment of medical cannabis distribution facilities; and Oregon and Vermont significantly reduced marijuana possession penalties.
#6 Cannabis Dispensaries Open In Washington, DC
Medical cannabis facilities opened for business in Washington, DC in 2013. The establishments are licensed and regulated by the District of Columbia, which finally unveiled its long-awaited medical marijuana program earlier this year. State-authorized dispensaries also opened for the first time this year in New Jersey, Rhode Island, and Vermont. Lawmakers in four states, Illinois, Oregon, Nevada and New Hampshire, enacted legislation in 2013 allowing for the establishment of medicinal cannabis facilities.
#7 Study: Blacks Arrested For Pot Offenses At Rates Four Times That Of Whites
African Americans are far more likely to be arrested for marijuana possession offenses than are whites, according to an American Civil Liberties Union (ACLU) report released in June that analyzed arrest data from 945 counties nationwide. The report found that blacks were approximately four times as likely as whites to be arrested for marijuana possession in 2010, even though both ethnicities consumed the substance at similar rates. Authors reported that the racial disparity in arrest rates had grown significantly over the past decade and that in some states African Americans were nearly eight times as likely as whites to be arrested for cannabis possession.
#8 FDA Approves Clinical Trials Of CBD In Cases Of Pediatric Epilepsy
The US Food and Drug Administration this fall granted approval for the importation of cannabidiol (CBD) extracts as an experimental treatment for a rare, intractable form of pediatric epilepsy known as Dravet syndrome. Preliminary clinical trials assessing the safety and tolerability of the compound in children are scheduled to begin in early 2014. Cannabidiol is a non-psychoactive cannabinoid that has been documented to possess a variety of therapeutic qualities, including anti-inflammatory, anti-diabetic, anti-epileptic, anti-cancer, and bone-stimulating properties.
#9 Study: No Association Between Cannabis Smoking And Lung Cancer
Subjects who regularly inhale cannabis smoke possess no greater risk of lung cancer than do those who consume it occasionally or not at all, according to data presented in May at the annual meeting of the American Academy for Cancer Research. UCLA investigators analyzed data from six case-control studies, conducted between 1999 and 2012, involving over 5,000 subjects (2,159 cases and 2,985 controls). They reported, “Our pooled results showed no significant association between the intensity, duration, or cumulative consumption of cannabis smoke and the risk of lung cancer overall or in never smokers.”
#10 Members Of Congress Introduce Legislation To End Federal Pot Prohibition
Members of Congress in February introduced historic legislation, HR 499: The Ending Federal Marijuana Prohibition Act, to remove cannabis from the control of the Drug Enforcement Administration and authorize the US Department of Treasury to license state-authorized retail marijuana producers and distributors. Although Congress refused to vote on the measure in 2013, it was the most-viewed legislation on the Congress.gov website.